Industry: Pharmaceuticals, Biotechnology
Osprey Pharmaceuticals Limited is a privately held biotechnology company focused on commercializing a unique family of therapeutic proteins capable of treating chronic diseases. Osprey’s broad technology platform is based on the critical insight that many common diseases are propagated by overabundant and overactive leukocytes. The company’s patented Leukocyte Population Modulators selectively and systematically destroy these disease-related leukocytes by infiltrating the chemokine system – a complex network of small proteins and their receptors that regulate the movement and activity of leukocytes. The company expects to initiate a Phase I/II trial for chronic kidney disease in the second half of ( www.ospreypharma.com )
Osprey Pharmaceuticals Limited
Suite 100
Saint-Laurent, Quebec H4S 2A1
Canada
Tel: (514) 336-3118
Fax: (514) 336-4072